MX2010001381A - Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos. - Google Patents

Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.

Info

Publication number
MX2010001381A
MX2010001381A MX2010001381A MX2010001381A MX2010001381A MX 2010001381 A MX2010001381 A MX 2010001381A MX 2010001381 A MX2010001381 A MX 2010001381A MX 2010001381 A MX2010001381 A MX 2010001381A MX 2010001381 A MX2010001381 A MX 2010001381A
Authority
MX
Mexico
Prior art keywords
hyodysenteriae
genes
proteins
animals
brachyspira
Prior art date
Application number
MX2010001381A
Other languages
English (en)
Inventor
Matthew Bellgard
David John Hampson
Tom La
Original Assignee
Spirogene Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spirogene Pty Ltd filed Critical Spirogene Pty Ltd
Publication of MX2010001381A publication Critical patent/MX2010001381A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen polinucleótidos y aminoácidos novedosos de Brachyspira hyodysenteriae. Estas secuencias son útiles para el diagnóstico de enfermedad de B. hyodysenteriae, en animales y como un tratamiento terapéutico o tratamiento profiláctico de enfermedad de B. hyodysenteriae en animales. Estas secuencias también son útiles para el tratamiento de diagnóstico y terapéutico y/o profiláctico en enfermedades en animales, originadas por otras especies Brachyspiras, incluyendo B. suanatina, B. intermedia, B. alvinipulli, B. aalborgi, B. innocens, B. murdochii, y B. pilosicoli.
MX2010001381A 2007-08-03 2007-08-03 Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos. MX2010001381A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/058049 WO2008017636A2 (en) 2006-08-09 2007-08-03 Genes and proteins of brachyspira hyodysenteriae and uses thereof

Publications (1)

Publication Number Publication Date
MX2010001381A true MX2010001381A (es) 2010-09-14

Family

ID=38667160

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001381A MX2010001381A (es) 2007-08-03 2007-08-03 Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.

Country Status (11)

Country Link
US (2) US8992938B2 (es)
EP (2) EP2185578A2 (es)
JP (1) JP2010535030A (es)
KR (2) KR20100080591A (es)
CN (1) CN101821284B (es)
AU (2) AU2007283667B2 (es)
BR (1) BRPI0721908A2 (es)
CO (1) CO6260101A2 (es)
MX (1) MX2010001381A (es)
UA (1) UA104714C2 (es)
WO (1) WO2008017636A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101821284B (zh) * 2007-08-03 2014-11-19 贝林格尔·英格海姆维特梅迪卡有限公司 猪痢疾短螺旋体的基因和蛋白质及其用途
EP2363407A1 (en) * 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
EP2530087B1 (en) * 2008-03-27 2018-05-02 Murdoch University Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
ES2922879T3 (es) 2012-12-21 2022-09-21 Boehringer Ingelheim Vetmedica Gmbh Proteínas recombinantes novedosas de la membrana externa de Brachyspira hyodysenteriae y usos de las mismas
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
EP3107864A4 (en) * 2014-02-17 2018-02-28 William Marsh Rice University Laser induced graphene materials and their use in electronic devices
MX2018008415A (es) * 2016-01-07 2018-12-10 Univ Gent Cepas de vacuna de brachyspira hyodysenteriae.

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
USRE31006E (en) 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4491632A (en) 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
DE3167442D1 (en) 1980-07-07 1985-01-10 Nat Res Dev Improvements in or relating to cell lines
US4341761A (en) 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4466917A (en) 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4451570A (en) 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4399121A (en) 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
JPH05502370A (ja) * 1989-09-13 1993-04-28 エムエル　テクノロジー　ヴェンチャーズ　エル．ピー． 分子量３９ｋＤａの赤痢病原体抗原およびそれに対する遺伝子暗号付与
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0486106A3 (en) 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
US6034298A (en) 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5877159A (en) 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US6150170A (en) 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5824538A (en) 1995-09-06 1998-10-20 The United States Of America As Represented By The Secretary Of The Army Shigella vector for delivering DNA to a mammalian cell
CA2305785A1 (en) 1997-10-07 1999-04-15 University Of Maryland Biotechnology Institute Method for introducing and expressing rna in animal cells
WO2001023537A1 (en) 1999-09-24 2001-04-05 Cyto Pulse Sciences, Inc. Process for enhancing electric field-mediated delivery of biological materials into cells
AU2001240109A1 (en) 2000-03-07 2001-09-17 U.S. Army Medical Research Institute Of Infectious Diseases Dna vaccines against poxviruses
AU2001250859A1 (en) 2000-03-16 2001-09-24 Joseph J. Drabick Method for gene transfection and vaccination through skin using electropermeabilization
JP2006500914A (ja) * 2002-05-08 2006-01-12 アクゾ・ノベル・エヌ・ベー ブタ赤痢（Ｂｒａｃｈｙｓｐｉｒａｈｙｏｄｙｓｅｎｔｅｒｉａｅ）ワクチン
CA2492716A1 (en) * 2002-07-17 2004-01-22 Akzo Nobel N.V. Brachyspira hyodysenteriae vaccine
AU2002953431A0 (en) * 2002-12-19 2003-01-09 Murdoch University BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
EP1697517A4 (en) * 2003-12-19 2007-02-28 Univ Murdoch BRACHYSPIRA PILOSICOLI EXTERNAL MEMBRANE PROTEIN OF 72KDA AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP1882035A2 (en) * 2005-05-12 2008-01-30 Novartis AG Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
AU2007229002A1 (en) * 2006-03-20 2007-09-27 Murdoch University Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
CN101821284B (zh) * 2007-08-03 2014-11-19 贝林格尔·英格海姆维特梅迪卡有限公司 猪痢疾短螺旋体的基因和蛋白质及其用途
EP2363407A1 (en) * 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
EP2530087B1 (en) * 2008-03-27 2018-05-02 Murdoch University Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
WO2010054437A1 (en) * 2008-11-14 2010-05-20 Spirogene Pty Ltd Vaccine strains of brachyspira hyodysenteriae

Also Published As

Publication number Publication date
AU2007283667B2 (en) 2014-09-04
US20110020383A1 (en) 2011-01-27
WO2008017636A2 (en) 2008-02-14
EP3018139A3 (en) 2016-08-10
US20160052974A1 (en) 2016-02-25
CN101821284A (zh) 2010-09-01
JP2010535030A (ja) 2010-11-18
BRPI0721908A2 (pt) 2014-02-25
EP2185578A2 (en) 2010-05-19
AU2007283667A1 (en) 2008-02-14
KR20100080591A (ko) 2010-07-09
KR20140120946A (ko) 2014-10-14
CO6260101A2 (es) 2011-03-22
WO2008017636A8 (en) 2009-10-01
US8992938B2 (en) 2015-03-31
EP3018139A2 (en) 2016-05-11
WO2008017636A3 (en) 2008-04-17
CN101821284B (zh) 2014-11-19
UA104714C2 (ru) 2014-03-11
AU2014213506A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
MX2010001381A (es) Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.
WO2009044273A3 (en) Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
MX2011010353A (es) Composicion farmaceutica.
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
MY164376A (en) Phosphospecific antibodies recognizing tau
NZ601538A (en) Vaccine compositions comprising a mutated factor h binding protein
IN2012DN04085A (es)
WO2007007173A3 (en) Human anti-madcam antibodies
NZ595387A (en) Peptides for treatment and diagnosis of autoimmune disease
MY156286A (en) Human il-23 antigen binding proteins
SI2104682T1 (sl) Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
EA201170190A1 (ru) Фармацевтическая композиция, содержащая экстракт мозга свиньи
WO2007107323A8 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2008135661A3 (fr) Utilisation de la citrulline pour pour le traitement de pathologies liees a une augmentation de la carbonylation des protéines
NZ601980A (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
TW200740997A (en) Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy
EP2271664A4 (en) NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF
EA201390867A1 (ru) Композиции на основе глины и обножки, способ их получения и их применение в питании и терапевтическом лечении
CY1115322T1 (el) Εκχυλισμα τριγωνελλας για τη θεραπεια νοσων στον ανθρωπο και τα ζωα στις οποιες εμπλεκονται μαστιγομορφα παρασιτα
WO2007113001A3 (en) Novel brachyspira pilosicoli genes and proteins and uses thereof
EP2811030A3 (en) Improved beta Thymosin fragments

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration